29 results
8-K
EX-99.1
AUTL
Autolus Therapeutics plc
5 Jun 24
Registered Number 11185179 (England & Wales) Annual Report and financial statements for the year ended 31 December 2023 for Autolus Therapeutics plc
4:35pm
lymphoma (“FL”), and chronic lymphocytic leukaemia (“CLL”). AUTOLUS THERAPEUTICS PLC Strategic Report For the year ended 31 December 2023 8
Furthermore
8-K
EX-99.2
AUTL
Autolus Therapeutics plc
17 May 24
Results of Operations and Financial Condition
8:27am
compartment fully – "T cell engagers did not appear to drive deep/durable remissions beyond treatment and as such would require chronic therapy
10-K
2023 FY
AUTL
Autolus Therapeutics plc
21 Mar 24
Annual report
4:55pm
large B-cell lymphoma (“DLBCL”), mantle cell lymphoma (“MCL”), follicular lymphoma (“FL”), and chronic lymphocytic leukemia (“CLL”).
Furthermore, obe
8-K
EX-99.2
AUTL
Autolus Therapeutics plc
11 Dec 23
Regulation FD Disclosure
8:31am
blasts without EMD) as measured at screening and lymphodepletion B-ALL, B-cell acute lymphoblastic leukemia; B-CLL, B-cell chronic lymphocytic leukemia … lymphoblastic leukemia; B-CLL, B-cell chronic lymphocytic leukemia; B-NHL, B-cell non-Hodgkin lymphoma; CAR, chimeric antigen receptor; obe-cel
8-K
EX-99.1
AUTL
Autolus Therapeutics plc
11 Dec 23
Regulation FD Disclosure
8:31am
), and a Phase Ib/II study (FELIX). Additionally, obe-cel has been tested in patients with R/R B-cell chronic lymphocytic leukemia (B-CLL) and R/R B-cell
6-K
EX-99.2
1lnoyysp2 0i
3 Aug 23
Index to Condensed Consolidated Financial Statements
4:32pm
6-K
EX-99.3
95hfv7 raj95qii2t
3 Aug 23
Index to Condensed Consolidated Financial Statements
4:32pm
6-K
EX-99.2
u6uu3pvqi3x7o3aubfud
4 May 23
Index to Condensed Consolidated Financial Statements
4:04pm
6-K
EX-99.3
x0s 0o00t
4 May 23
Index to Condensed Consolidated Financial Statements
4:04pm
424B5
i6job 9fhigapc5w236o
9 Dec 22
Prospectus supplement for primary offering
5:40pm
424B5
01a 9o0njdiz
8 Dec 22
Prospectus supplement for primary offering
4:10pm
6-K
EX-99.2
0t6q4a5s7f10wxndbg
4 Aug 22
Index to Condensed Consolidated Financial Statements
4:06pm
6-K
EX-99.3
7qpfhvs 6zu3y0jt
4 Aug 22
Index to Condensed Consolidated Financial Statements
4:06pm
424B5
n9m4uztc
19 Aug 21
Prospectus supplement for primary offering
4:13pm
F-3
jyqsk 1s0c16uq
6 Aug 21
Shelf registration (foreign)
2:30pm
6-K
EX-1
uuuh7m 4z
30 Jun 21
Annual Report and Accounts
6:05am
424B5
5x1133xt bquw89
11 Feb 21
Prospectus supplement for primary offering
5:16pm
424B5
311kqj
8 Feb 21
Prospectus supplement for primary offering
5:27pm